Distinguished Alumni Awards Honor Exceptional ENG Grads

in Alumni, Awards, Events, News-CE, News-EP, News-ISS, Recognition
November 19th, 2013

Dean Kenneth R. Lutchen with Anton Papp (EE '90) (top), Dan Ryan and Aaron Ganick (both ECE '10) (middle) and George Savage (BME '81) (bottom) (Photos by Dave Green)

Dean Kenneth R. Lutchen with Anton Papp (EE '90) (Photo by Dave Green)

In a ceremony held October 25 at the Boston University Photonics Center, the College of Engineering celebrated its alumni and announced the 2013 Distinguished Alumni Awards. Presented by Dean Kenneth R. Lutchen following a buffet dinner and champagne toast, the awards recognize individuals who have made significant contributions to their alma mater, community and profession. Lutchen commended the recipients for bringing honor to the College through their careers, commitment to the highest standards of excellence, and devotion to the College.

Anton Papp (EE ’90), vice president for Corporate Development at Teradata, received the Service to Alma Mater award, which honors alumni who have enhanced the College of Engineering’s stature through voluntary service to BU.

Dean Kenneth R. Lutchen (center) with Dan Ryan (left) and Aaron Ganick (both ECE '10) (Photo by Dave Green)

Dean Kenneth R. Lutchen (center) with Dan Ryan (left) and Aaron Ganick (both ECE '10) (Photo by Dave Green)

At Teradata Papp oversees, evaluates and executes investments, mergers and acquisitions, and strategy. Prior to joining Teradata, he served as vice president of Corporate Development & Global Alliances at Aprimo and held numerous investment banking positions. A graduate of the prestigious US Navy Fighter Weapons School (TOPGUN), Papp attended BU on a Naval ROTC scholarship and served as a Naval Officer and F-14 Tomcat Flight Instructor. He also earned an MBA in Finance from Columbia Business School.

Papp serves on the College of Engineering Dean’s Advisory Board, the ENG West Coast Alumni Leadership Council, and the BU West Coast Regional Campaign Committee. He has been the leading supporter for the ENG/SMG Summer Leadership Institute program, and part of the College’s efforts to recruit top undergraduates.

Dan Ryan and Aaron Ganick (both ECE ’10), cofounders of the telecommunications company ByteLight, received the Distinguished Young Alumni award, which honors outstanding alumni within 10 years of graduation for outstanding service to their profession or community.

Dean Kenneth R. Lutchen and George Savage (BME '81) (Photo by Dave Green)

Dean Kenneth R. Lutchen and George Savage (BME '81) (Photo by Dave Green)

A startup that emerged out of the Smart Lighting Engineering Research Center at BU, ByteLight has produced a system that’s similar to an indoor GPS. Special LED lights provided by Bytelight enable your smartphone to determine your location and to bring up location-based information ranging from store coupons to museum exhibit descriptions.

George Savage (BME ’81), Chief Medical Officer and cofounder of Proteus Digital Health, and a member of the BU College of Engineering West Coast Advisory Council, received the Service to the Profession award, which honors alumni whose work has significantly contributed to the advancement of their profession and brought them recognition within their field.

Savage has started 10 companies since 1989 as entrepreneur or founding investor, including FemRx (acquired by Johnson and Johnson), CardioRhythm (acquired by Medtronic) and QRx Pharmaceuticals. He holds an M.D. from Tufts University School of Medicine and an M.B.A. from Stanford University Graduate School of Business, and serves on the boards of Menlo Healthcare Ministry, the Pacific Research Institute and Silent Cal Productions.

At Proteus, Savage has advanced a system of small, ingestible event markers that are implanted in a patient’s medications. A monitor worn as a patch on the patient identifies each pill upon swallowing and tracks vital signs, which are uploaded to the patient’s mobile phone and transmitted to caregivers and healthcare professionals. The system allows for instantaneous and personalized treatment and promises to transform the way doctors monitor patients’ medicine.

-Mark Dwortzan